Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2023 Q1- Text added to 2023 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
algorithm, angiography, audience, Austrian, CEO, CRP, diameter, distal, Endocrinology, ERC, EVAPORATE, exceeded, Expert, FFRCT, firsthand, fractional, headcount, Holt, IIT, imaging, inadequate, Kaiser, Korea, leadership, lesion, lingering, NJ, online, ORP, physiology, preexisting, pursuit, redesign, redesigned, refocused, resignation, retention, South, Southeast, Spain, sparking, timeline, titrating, translesional, vessel, wake
Removed:
accessibility, amid, area, attributed, background, bioresearch, call, Cardiology, certiorari, created, CVD, defer, denied, destabilized, FDC, hoc, impactfully, impeding, inducing, interactive, median, mixed, petition, post, reevaluate, refining, reinstated, reinstating, remote, resuming, routine, shortage, showed, sizing, stable, stepwise, syndrome, Trump, writ
Valuein 2023 Q1 filing- Value in 2023 Q2 filing
Original filings
Filing view